Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics.
Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.
By:
Monique Elseviers (University of Antwerp Belgium),
Björn Wettermark (Karolinska Institutet,
Sweden),
Anna Birna Almarsdóttir (University of Southern Denmark,
Denmark),
Morten Andersen (Karolinska Institutet,
Sweden),
Ria Benkö (University of Szeged,
Hungary)
Imprint: Wiley-Blackwell
Country of Publication: United States
Dimensions:
Height: 254mm,
Width: 198mm,
Spine: 31mm
Weight: 1.102kg
ISBN: 9781118949788
ISBN 10: 1118949781
Pages: 536
Publication Date: 13 May 2016
Audience:
Professional and scholarly
,
Undergraduate
Replaced By: 9781119911654
Format: Hardback
Publisher's Status: Active
List of contributors viii Acknowledgements xiv About the companion website xix Part 1 Introduction 1 Introduction to drug utilization research 3 Björn Wettermark, Monique Elseviers, Anna Birna Almarsdóttir, Morten Andersen, Ria Benko, Marion Bennie, Irene Eriksson, Brian Godman, Janet Krska, Elisabetta Poluzzi, Katja Taxis, Robert Vander Stichele, Vera Vlahovic-Palcevski Part 2 Methodology 2 Study designs in drug utilization research 15 Björn Wettermark, Mirko Di Martino, Monique Elseviers 3 Primary data collection for drug utilization research 29 Tatiana Chama Borges Luz, Evalill Nilsson 4 Secondary data sources for drug utilization research 39 Irene Eriksson, Luisa Ibáñez 5 Classifi cation systems for drugs and diseases 49 Marit Rønning, Stuart McTaggart 6 Measurement units of drug utilization 58 Hege Salvesen Blix 7 Individual-level drug utilization analyses 68 Jesper Hallas, Henrik Støvring, Anton Pottegård 8 Measurement of drug expenditure 77 Sabine Vogler, Jaana E. Martikainen 9 Basic statistical methods in drug utilization research 88 Douglas T. Steinke, Monique Elseviers 10 Visualization of drug utilization data 99 Maria Matuz, Ria Benko, Mikael Hoffmann 11 Multilevel analyses in drug utilization research 116 Juan Merlo 12 Defi ning and developing quality indicators for drug utilization 126 Stephen Campbell, Björn Wettermark, Morten Andersen 13 Qualitative methods in drug utilization research 139 Anna Birna Almarsdóttir, Pia Bastholm Rahmner Part 3 Applied drug utilization research Section A Comparative drug utilization research 14 Comparison of drug utilization across different geographical areas 153 Vera Vlahovic-Palcevski, Björn Wettermark, Luisa Ibáñez, Robert Vander Stichele 15 Comparison of drug utilization in different health care settings 160 Sean MacBride-Stewart, Ksenia Zagorodnikova, Irene Langner, Gisbert W. Selke 16 Time-dependent and seasonal variations in drug utilization 173 Eric Van Ganse, Laurent Laforest, Niels Adriaenssens 17 Comparative studies of patient and prescriber characteristics 184 Irene Eriksson, Ulf Bergman, Vera Vlahovic-Palcevski, Mia von Euler 18 Comparative studies of health systems 194 Tatiana Chama Borges Luz, Claudia Garcia Serpa Osorio-de-Castro, Björn Wettermark Section B Drug utilization and health policy 19 Drug utilization and health policy 203 Brian Godman, Hye Young Kwon, Marion Bennie, Anna Birna Almarsdóttir 20 Managed introduction of new drugs 210 Brian Godman, Roberta Joppi, Marion Bennie, Saira Jan, Björn Wettermark 21 Management of drugs in the health care system 222 Brian Godman, Marion Bennie, Claudia Garcia Serpa Osorio‐de‐Castro, Vu Thi Thu Huong, Saira Jan 22 The pharmaceutical industry and health policy 231 Richard Torbett, Donald Han, Indranil Bagchi Section C Drug utilization in specific populations 23 Drug utilization in pregnant women 240 Hedvig Nordeng 24 Drug utilization in the paediatric population 248 Antje Neubert, Katja Taxis, Ian C.K. Wong 25 Drug utilization in older people 259 Katja Taxis, David O’Sullivan, Shane Cullinan, Stephen Byrne Section D Drug utilization in specific therapeutic areas 26 Drug utilization research in the area of antibiotics 270 Ria Benko, Marion Bennie, Samuel Coenen 27 Drug utilization research in the area of cardiovascular medicines 284 Elisabetta Poluzzi, Maarit Jaana Korhonen 28 Drug utilization research in the area of analgesics and psychotropics 294 Helga Zoëga, Alesha Smith, Nadia Barozzi 29 Drug utilization research in the area of biologicals 302 Carlo Piccinni, Luigi Naldi, Martin Neovius 30 Drug utilization research in the area of cancer drugs 315 Nils Wilking, Thomas Hofmarcher, Ulla Wilking, Bengt Jönsson Section E Determinants of drug utilization 31 Health system perspectives 328 Paul Spivey, Brian Godman 32 Prescriber perspectives 336 Colin Bradley, Kathleen Holloway, Janet Krska 33 Patient perspectives 347 Janine Traulsen, Nicky Britten, Janet Krska Section F Adherence and drug utilization research 34 An introduction to adherence research 355 Bernard Vrijens 35 Assessment of medication adherence in field research 361 Monique Elseviers, Bernard Vrijens 36 Assessment of adherence to drug treatment in database research 369 Jean-Pierre Grégoire, Jocelyne Moisan 37 Interventions to improve adherence to drug treatment 381 Marie-Paule Schneider, Jennifer Celio, Yoleen van Camp, Matthias Cavassini Section G The role of drug utilization within the field of pharmacoepidemiology 38 Drug utilization research and risk management 392 Giampiero Mazzaglia, Peter Mol 39 Drug utilization research and pharmacovigilance 399 Emanuel Raschi, Fabrizio De Ponti 40 Drug utilization research and the regulator’s perspective in pharmacovigilance 408 Xavier Kurz, Kevin Blake 41 Drug utilization research and outcomes research 417 Henrik Toft Sørensen, Gianluca Trifi rò 42 Drug utilization research and pharmacoeconomics 425 Cara Usher, Kathleen Bennett, Lorenzo G. Mantovani, Dyfrig Hughes Section H Assessment and improvement of the quality of medicine use 43 Assessment of quality of prescribing using quality indicators 433 Petra Denig, Flora Haaijer-Ruskamp, Lisa Pont 44 Quality indicators for patient care in pharmacy practice 443 Hanne Herborg 45 Interventions that infl uence prescribing decisions and drug utilization 460 Jens Søndergaard, Dorte Gilså Hansen, Debra Rowett 46 Development, delivery and evaluation of implementation programmes 468 Elizabeth Roughead, Andrew Gilbert 47 Towards a better understanding of prescribingenhancement interventions 477 Frank May Part 4 Epilogue 48 The many futures of drug utilization research 489 Hubert G.M. Leufkens, Frank May, Nicky Britten Glossary 492 Index 497
Monique Elseviers, Centre for Research and Innovation in Care, University of Antwerp, Belgium. Björn Wettermark, Associate Professor in Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. Morten Andersen, Visiting Professor, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden; Senior Physician at the Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Senior Researcher at the Research Unit for General Practice, University of Southern Denmark, Denmark. Ria Benko, Associate Professor, Department of Clinical Pharmacy at the University of Szeged, Hungary. Marion Bennie, Professor of Pharmacy Practice, University of Strathclyde, UK; Chief Pharmaceutical Adviser, NHS National Services Scotland, UK. Brian Godman, Research Scientist, Karolinska Institutet, Stockholm, Sweden. Janet Krska, Professor of Clinical and Professional Pharmacy, Medway School of Pharmacy, Universities of Greenwich and Kent, UK. Elisabetta Poluzzi, Assistant Professor of Pharmacology, Department of Pharmacology, Faculty of Medicine, University of Bologna, Italy. Katja Taxis, Associate Professor of Pharmacotherapy and Clinical Pharmacy, University of Groningen, Netherlands. Vera Vlahovic-Palcevski, Professor, Department of Pharmacology, University of Rijeka Medical School, Croatia; Specialist in Clinical Pharmacology, University Hospital Rijeka, Croatia. Robert Vander Stichele, practicing family physician in Ghent, Belgium.
Reviews for Drug Utilization Research: Methods and Applications
"""Overall, this is a great resource for healthcare providers and a great learning tool for students. It is well written and includes many helpful figures and tables. The references to specific pages for more in-depth explanations of certain topics make this book very user friendly."" (Doody Enterprises, 2016)"